Log In
BCIQ
Print this Print this
 

NX001

  Manage Alerts
Collapse Summary General Information
Company NephRx Corp.
DescriptionKidney growth factor peptide
Molecular Target
Mechanism of Action 
Therapeutic ModalityPeptide
Latest Stage of DevelopmentPhase I
Standard IndicationRenal transplant rejection
Indication DetailsPrevent delayed graft function (DGF) after renal transplantation
Regulatory Designation U.S. - Orphan Drug (Prevent delayed graft function (DGF) after renal transplantation)
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today